ArticleCell death & disease2026
Pro-inflammatory cytokine IFN-γ protects against renal fibrosis by promoting E3 ubiquitin ligase Trim21-mediated Loxl2 degradation in tubular epithelial cells.
Article in Cell death & disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The excessive accumulation of extracellular matrix (ECM) is a hallmark of renal interstitial fibrosis, its underlying mechanisms are incompletely understood. Here, we identify the E3 ubiquitin ligase Tripartite motif-containing protein 21 (Trim21) as a key regulator of this process. We found that Trim21 is upregulated in the tubular cells of fibrotic kidneys from both chronic kidney disease (CKD) patients and mouse models. Using tubular cell-specific Trim21 knockout mice, we demonstrated that Trim21 induction protects against ECM accumulation and renal fibrosis. Mechanistically, Trim21 binds to the N-terminal domain of Lysyl Oxidase-like 2 (Loxl2), promoting its ubiquitination and degradation, which in turn alleviates ECM deposition. Furthermore, we observed an upregulation of interferon-γ (IFN-γ) and its receptor in tubular cells during fibrosis. IFN-γ treatment increased Trim21 expression, reduced Loxl2 expression and renal fibrosis; critically, this protective effect was abolished in tubular-specific Trim21 knockout mice. In summary, our study defines a protective IFN-γ/Trim21/Loxl2 axis in the kidney, wherein IFN-γ signaling induces Trim21 to target Loxl2 for degradation, thereby mitigating fibrosis.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.